Both conversions resulted in unfavorable variants, while in two cases with conversion from luminal A to luminal B (HER2+) the administered chemotherapy was probably insufficient due to hormone therapy alone prescribed according to the luminal A primary tumor. The gene discussed is ERBB2; the disease is neoplasm.